Arcadia Biosciences RKDA
NASDAQ RKDA
$0.15 -0.01 (-6.89%)
As of: Nov 11, 2026 · 11:26 AM EST

Arcadia Biosciences (RKDA) Accumulated Expenses (2014 - 2025)

Updated

Arcadia Biosciences' Accumulated Expenses came in at $45,000 for Q4 2020, down 92.8% from $629,000 a year earlier.

Analysis

Arcadia Biosciences (RKDA) Accumulated Expenses (2014 - 2025) Analysis & Trends

Going back to Q4 2014, Arcadia Biosciences' Accumulated Expenses data covers 7 quarters.

  • Accumulated Expenses carries a five-year compound annual growth rate of -32.6% (FY2015 to FY2020).
  • Going back by year, Accumulated Expenses was $629,000 in FY2019 (+45.3%), $433,000 in FY2018 (-51.8%), $899,000 in FY2017 (+394.0%) and $182,000 in FY2016 (-43.7%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Coca Cola 416.85 Bn 405.33 Bn 8.45 Bn
2 Diageo 246.91 Bn 229.06 Bn -
3 Coca Cola Femsa Sab De Cv 201.88 Bn 201.88 Bn 37.08 Bn
4 Pepsico 195.70 Bn 153.66 Bn 13.75 Bn
5 Anheuser-Busch InBev 154.67 Bn 154.67 Bn 27,528.00
6 Monster Beverage 88.75 Bn 85.98 Bn 1.40 Bn
7 Coca-Cola Europacific Partners 52.79 Bn 46.01 Bn -
8 Keurig Dr Pepper 51.16 Bn 50.63 Bn 3.53 Bn
9 Ambev 43.82 Bn 28.73 Bn 2.14 Bn
10 Arcadia Biosciences 508,734.36 -17.91 Mn 631,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 16,000.00
Dec 31, 2024 16,000.00
Dec 31, 2023 16,000.00
Dec 31, 2022 75,000.00
Dec 31, 2021 16,000.00
Dec 31, 2020 45,000.00
Dec 31, 2019 629,000.00
Dec 31, 2018 433,000.00
Dec 31, 2017 899,000.00
Dec 31, 2016 280,000.00
Dec 31, 2015 332,000.00
Dec 31, 2014 237,000.00
API Access

Arcadia Biosciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RKDA&period=max&api_key=YOUR_API_KEY